Melissa Lambert
Nurse Practitioner · Omaha, NENPI 1497040174
Payments from drug & device makers
Across 46 payments — averaging $20.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$121
- AbbVie$112
- Dermavant Sciences, Inc.$92
- Biogen$86
- Exeltis, USA Inc.$78
- Astellas Pharma US Inc$70
- plus $381 from 16 others
What the payments were for
- Food & beverage$940100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $121 |
| AbbVie | 6 | $112 |
| Dermavant Sciences, Inc. | 1 | $92 |
| Biogen | 4 | $86 |
| Exeltis, USA Inc. | 5 | $78 |
| Astellas Pharma US Inc | 3 | $70 |
| Mayne Pharma Commercial LLC | 4 | $55 |
| Organon | 2 | $45 |
| Pfizer | 3 | $41 |
| Medtronic | 1 | $30 |
| UCB, Inc. | 1 | $25 |
| Radius Health, Inc. | 1 | $24 |
| Botanix SB Inc | 1 | $22 |
| AMAG Pharmaceuticals, Inc. | 1 | $21 |
| Evofem Biosciences, Inc. | 1 | $18 |
| Amgen | 1 | $17 |
| Myovant Sciences Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
| Merck | 1 | $13 |
| Avion Pharmaceuticals | 1 | $12 |
How this compares
$940 in reported general payments places this provider in the 70th percentile of 924 nurse practitioner providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Omaha
- Kristen HammesOmaha$899K
- Amy MuchowiczOmaha$78K
- Kari CunninghamOmaha$53K
- Laura DonovanOmaha$49K
- Kathleen HealeyOmaha$36K
- Katie RuchOmaha$26K
- Amanda GuggenmosOmaha$23K
- Amy YagerOmaha$15K
- Cara SchiesslerOmaha$14K
- Lindsay OneilOmaha$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.